Hokkaido University · Faculty of Medicine / Graduate School of Medicine / Medical Research Institute · 特任助教

Research keywordshepatoblastoma・cisplatin resistance・SGLT2 inhibition・DLK1-DIO3 microRNA cluster・CSF3R hypermethylation・biliary atresia・portoenterostomy timing・congenital portosystemic shunt

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• PAGE4, upregulated in a novel iPSC-derived hepatoblastoma model, promotes hepatoblastoma progression.2025 · Biochemical and biophysical research communications, 790, 152824, 152824, 2025年10月16日,
• SGLT2 is upregulated to acquire cisplatin resistance and SGLT2 inhibition reduces cisplatin resistance in hepatoblastoma.2024 · Journal of hepato-biliary-pancreatic sciences, 31, 4, 223, 233, 2024年04月,
• Unusual rapid development of portopulmonary hypertension after shunt closure for congenital portosystemic shunt.2024 · Journal of paediatrics and child health, 2024年08月06日,
• Assessing the risk factors for surgical site infections after anal reconstruction surgery in patients with anorectal malformations: a retrospective analysis.2024 · Pediatric surgery international, 41, 1, 41, 41, 2024年12月21日,

• Official profile